Project Grant HT94252310835
Award Date
9/15/23
Completion Date
9/14/25
Dollars Obligated
$377K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Kalamazoo, MI 49008, USA
Similar Awards
This $385,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Wayne State University's research to develop therapeutic approaches targeting spiral ganglion-cochlear nucleus synaptopathy. The two-year award, running from September 1, 2023 to August 31, 2025, aims to transform health care for Service Members and the American public through innovative and impactful biomedical research. As a prominent public...
The Department of the Army Medical Command awarded Case Western Reserve University a $795,901 project grant under the Military Medical Research and Development program (CFDA 12.420). The university will develop a novel agent targeting microglial activation induced by therapeutic brain irradiation over a three year period ending August 31, 2025. Through this funding, the awardee aims to investigate medical solutions for the battlefield and transform health care for service members and the...
The Department of the Army Medical Command awarded a $1,170,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, awarded on May 15, 2025, supports research to develop systemically administered bispecific antibodies that activate neurotrophin receptors for treating noise-induced inner ear damage. The University of Michigan, a leading public research institution, will leverage its extensive research...
The University of Michigan will receive $780,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to conduct a mixed-methods study from September 2021 through August 2024. The study will examine the risk of Alzheimer's disease and related dementias among people with spinal cord injuries, comparing veterans and civilians. Through supporting innovative medical research, the Military Medical Research and Development program...
The University of Michigan will receive $1.5 million from the Department of the Army Medical Command under a three-year Project Grant award to support biomarker-guided brain CT imaging research in traumatic brain injury. The grant, issued under the Military Medical Research and Development program (CFDA 12.420), will fund efforts from September 2022 to September 2025 to investigate medical solutions for traumatic brain injuries on the battlefield through innovative and impactful research that...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
This Project Grant award of $731,980.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The award will fund a research project titled "A DATA-DRIVEN APPROACH TO INDIVIDUALIZED CONCUSSION RISK PREDICTION IN U.S. SERVICE ACADEMY CADETS AND MIDSHIPMEN" from August 1, 2024 to July 31, 2027. The project aims to develop an individualized concussion risk prediction model for...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $400,400.00 to Wayne State University to conduct research aimed at "Harnessing Immunometabolism to Ameliorate the Pathology of Ocular Chemical Injuries." The award, which runs from July 1, 2025 to June 30, 2027, supports advanced biomedical research to transform healthcare for military service members and the broader public....